483 Octapharma Plasma Mar 2022

483 Octapharma Plasma Mar 2022

Fabian Chaparro-Rodriguez FDA, Laressa Gray FDA$119.00 - Available Now

FDA investigators audited the Octapharma Plasma - Knoxville, TN, United States facility and issued inspectional observations (via FDA 483) on 04 Mar 2022.

Product details

  • Category: Biologics
  • Inspection end: 04 Mar 2022
  • Location: Knoxville, United States
  • FEI: 3017028977
Add To Cart